Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.8
39.30%
40%
—
-100.00%
40%
—
5 Years
Score3.8
Net Growth39.30%
Net Trend40%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend40%
Revenue Consistency—
INmune Bio Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 10.92K to $ 50K and net income went from -$ 12M to -$ 45M. Revenue increased in 2 of those 5 years; net income in 2.
INmune Bio Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.04 | — |
1 Year2025-08-12 | $ 2.42 | -15.70% |
5 Years2021-08-12 | $ 16.85 | -87.89% |
All Time2019-02-04 | $ 7.99 | -74.47% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-02-04 |
|---|---|---|---|---|
| Price | $ 2.04 | $ 2.42 | $ 16.85 | $ 7.99 |
| Return | — | -15.70% | -87.89% | -74.47% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 18M | $ 18M |
| 2025 | $ 50K | -$ 45M | $ 24M |
| 2024 | $ 14K | -$ 42M | $ 20M |
| 2023 | $ 155K | -$ 30M | $ 35M |
| 2022 | $ 374K | -$ 28M | $ 52M |
| 2021 | $ 181K | -$ 30M | $ 74M |
| 2020 | $ 10.92K | -$ 12M | $ 21M |
| IPO2019 | $ 77M | -$ 7M | $ 6M |
Explore beyond INMB
You're looking at INmune Bio Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
